This organ-on-a-chip device may improve heart disease treatment

Image
IANS Singapore
Last Updated : Jan 03 2018 | 3:51 PM IST

Researchers have developed an organ-on-a-chip device that can mimic the functions of human heart and help researchers better understand atherosclerosis -- the constriction of blood vessels -- the leading cause of heart attacks and strokes.

The new device can be used to study important inflammatory responses in cells that line the vessel in ways that could not be done in animal models as well as could improve blood testing for patients.

Atherosclerosis develops when fat, cholesterol and other substances in the blood form plaque that accumulates on the inside walls of arteries. This buildup constricts the blood vessel, causing cardiovascular diseases.

Understanding what regulates this abnormal vessel constriction is crucial to studying and treating vessel disease and preventing acute cardiac arrest, the researchers said.

"Previously developed organ-on-a-chip models blood vessels, and focus more on recreating the vessel's biological complexity than on its shape and geometry -- which are key factors in atherosclerosis," said Han Wei Hou, a biomedical engineer at Nanyang Technological University in Singapore.

"The disease involves not just the biological aspect of endothelial dysfunction, but also the biomechanics of blood flow," Hou said.

In the study, appearing in the journal APL Bioengineering, the researchers pumped blood spiked with TNF-alpha -- a protein that's a sign of inflammation, into their device.

The inflamed blood caused more immune cells to bind to the endothelial cells than normal.

Measuring the number of bound immune cells could reveal the level of inflammation in the blood -- an indicator of early atherosclerosis.

In contrast to other tests that just count the number of immune cells circulating in blood, this technique could more accurately assess early immune responses in patients, the researchers said.

"The new model can more accurately simulate atherosclerosis because (the) researcher can precisely tune constriction by controlling the air pressure," Hou said.

"(The device) has a lot of promise in terms of diagnostics," Hou added.

--IANS

rt/umer/vm

Disclaimer: No Business Standard Journalist was involved in creation of this content

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 03 2018 | 3:14 PM IST

Next Story